Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 3206 (112th)

Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011

referredUnited States· United States Congress· EN

Introduced

14 October 2011

Last action

18 October 2011 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Burgess, Michael C. [R-TX-26], Sen. Cassidy, Bill [R-LA], Rep. Bilbray, Brian P. [R-CA-50], Rep. Gingrey, Phil [R-GA-11], Rep. Paulsen, Erik [R-MN-3], Rep. Guthrie, Brett [R-KY-2], Sen. Blackburn, Marsha [R-TN], Rep. Shimkus, John [R-IL-15], Rep. Latta, Robert E. [R-OH-5], Rep. Culberson, John Abney [R-TX-7], Rep. Walden, Greg [R-OR-2], Rep. Bucshon, Larry [R-IN-8], Rep. McCaul, Michael T. [R-TX-10], Rep. Rokita, Todd [R-IN-4], Rep. Matheson, Jim [D-UT-2], Rep. Barrow, John [D-GA-12]

Subjects

Healthcare

Source updated

14 August 2025

Healthcare

Summary

Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011 - Amends the Federal Food, Drug, and Cosmetic Act to revise provisions related to financial interests of Food and Drug Administration (FDA) advisory committee members to require the Secretary of Health and Human Services (HHS) to ensure that individual appointments to advisory committees are made to promote scientific and technical expertise while at the same time minimizing any potential conflicts of interest. Requires the Secretary to consider, with respect to any financial interest constituting a potential conflict of interest, the type, nature, and magnitude of the financial interest. Declares that no specific factor shall be dispositive in the Secretary's evaluation of a particular financial interest. Repeals the prohibition specifically applicable to FDA that prevents a member of an advisory committee from participating with respect to a particular matter if such individual or an immediate family member of such individual has a financial interest that could be affected by the advice given to the Secretary.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 14 October 2011

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 14 October 2011

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 14 October 2011

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 18 October 2011

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 14 October 2011

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 14 October 2011

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 14 October 2011

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.